Abstract
Matrix-assisted laser desorption/ionization-tandem mass spectrometric method (MALDI-MS/MS) has proven to be a reliable tool for direct measurement of the disposition of small molecules in animal tissue sections. As example, MALDI-MS/MS imaging system was employed for visualizing the spatial distribution of astemizole and its primary metabolite in rat brain tissues. Astemizole is a second-generation antihistamine, a block peripheral H1 receptor, which was introduced to provide comparable therapeutic benefit but was withdrawn in most countries due to toxicity risks. Astemizole was observed to be heterogeneously distributed to most parts of brain tissue slices including cortex, hippocampus, hypothalamic, thalamus, and ventricle regions while its major metabolite, desmethylastemizole, was only found around ventricle sites. We have shown that astemizole alone is likely to be responsible for the central nervous system (CNS) side effects when its exposures became elevated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Simons, F. E. (1994) The therapeutic index of newer H1-receptor antagonists. Clin Exp Allergy, 24, 707–723.
Simons, F. E. (1999) Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early treatment of the atopic child. J Allergy Clin Immunol, 104, 433–440.
Passalacqua, G., Bousquet, J., Bachert, C., Church, M. K., Bindsley-Jensen, C., Nagy, L., Szemere, P., Davies, R. J., Durham, S. R., Horak, F., Kontou-Fili, K., Malling, H. J., Cauwenberge, P., Canonica, G. W. (1996) The clinical safety of H1-receptor antagonists. Allergy, 51, 666–675.
Estelle, F., Simons, R. (1999) H1-receptor antagonists: safety issues. Ann Allergy Asthma Immunol, 83, 481–488.
Horak, F., Stubner, U. P. (1999) Comparative tolerability of second generation antihistamines. Drug Saf, 20, 385–401.
Jansen, F. P., Wu, T. S., Voss, H. P., Steinbusch, H. W., Vollinga, R. C., Rademaker, B., Bast, A., Timmerman, H. (1994) Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain. Br J Pharmacol, 113, 355–362.
Alves-Rodrigues, A., Timmerman, H., Willems, E., Lemstra, S., Zuiderveld, O. P., Leurs, R. (1998) Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus. Brain Res, 788, 179–186.
Khatib-Shahidi, S., Andersson, M., Herman, J. L., Gillespie, T. A. Caprioli, R. M. (2006) Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal Chem, 78, 6448–6456.
Hsieh, Y., Casale, R., Fukuda, E., Chen, J., Knemeyer, I., Wingate, J., Morrison, R., Korfmacher, W. A. (2006) Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun Mass Spectrom, 20, 965–972.
Hsieh, Y., Chen, J., Korfmacher, W. A. (2007) Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry. J Pharmacol Toxicol Methods, 55, 193–200.
Reyzer, M. L., Hsieh, Y., Ng, K., Korfmacher, W. A., Caprioli, R. M. (2003) Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom, 38, 1081–1092.
Stoeckli, M., Staab, D., Schweitzer, A., Gardiner, J., Seebach, D. (2007) Imaging of a beta-peptide distribution in whole-body mice sections by MALDI mass spectrometry. J Am Soc Mass Spectrom, 18, 1921–1924.
Chaurand, P., Norris, J. L., Cornett, D. S., Mobley, J. A., Caprioli, R. M. (2006) New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res, 5, 2889–2900.
Chaurand, P., Sanders, M. E., Jensen, R. A., Caprioli, R. M. (2004) Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol, 165, 1057–1068.
Chaurand, P., Schwartz, S. A., Billheimer, D., Xu, B. J. Crecelius, A. Caprioli, R. M. (2004) Integrating histology and imaging mass spectrometry. Anal Chem, 76, 1145–1155.
Chaurand, P., Schwartz, S. A., Caprioli, R. M. (2002) Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol, 6, 676–681.
Chaurand, P., Schwartz, S. A., Caprioli, R. M. (2004) Assessing protein patterns in disease using imaging mass spectrometry. J Proteome Res, 3, 245–252.
Chen, J., Hsieh, Y., Crossman, L., Knemeyer, I., Korfmacher, W. A. (2008) Visualization of first-pass drug metabolism of terfenadine by MALDI-imaging mass spectrometry. Drug Metab Lett, 2, 1–4.
Li, F., Hsieh, Y., Kang, L., Sondey, C., Lachowicz, J., Korfmacher, W. A. (2009) MALDI-tandem mass spectrometry imaging of astemizole and its primary metabolite in rat brain sections. Bioanalysis, 1, 299–307.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hsieh, Y., Li, F., Korfmacher, W.A. (2010). Mapping Pharmaceuticals in Rat Brain Sections Using MALDI Imaging Mass Spectrometry. In: Rubakhin, S., Sweedler, J. (eds) Mass Spectrometry Imaging. Methods in Molecular Biology, vol 656. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-746-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-60761-746-4_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-745-7
Online ISBN: 978-1-60761-746-4
eBook Packages: Springer Protocols